A novel gas phase method for the combined synthesis and coating of pharmaceutical particles

Pharmaceutical Research

Volumn 25, Issue 1, 2008, Pages 242-245

  Raula, Janne ^a   Lähde, Anna ^a   Kauppinen, Esko I ^a,b  

^a AALTO UNIVERSITY   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Aerosol; Coating; Evaporation; Gas phase deposition; Inhalation; L leucine; Pharmaceutical; Powder production; Salbutamol sulfate; Surface modification; Vapor

Indexed keywords

LACTOSE; LEUCINE; SALBUTAMOL SULFATE;

AIRFLOW; ARTICLE; CRYSTALLIZATION; DRUG STABILITY; DRUG SYNTHESIS; FLOW KINETICS; GAS; HUMIDITY; MATERIAL COATING; PARTICLE SIZE; PHYSICAL VAPOR DEPOSITION; PRIORITY JOURNAL; SURFACE PROPERTY; TECHNIQUE; VAPOR;

AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; DRUG COMPOUNDING; GASES; LEUCINE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE;

EID: 38049119839     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9464-4     Document Type: Article

References (18)

1. S. Budavari, M. J. O'Neil, A. Smith, and P. E. Heckelman (eds.), The Merck Index, 11th edition, 1989.
2. N. Y. K. Chew, B. Y. Shekunov, H. H. Y. Tong, A. H. L. Chow, C. Savage, J. Wu, and H.-K. Chan. Effect of amino acids on the dispersion of disodium cromoglycate powders. J. Pharm. Sci. 94:2289-2300 (2005).
3. S. Chungi, and T. I. Iorio. Method for coating drug-containing particles and formulations and dosage units formed therefrom. WO 04/84866 (2004).
4. H. Eerikäinen, W. Watanabe, E. I. Kauppinen, and P. P. Ahonen. Aerosol flow reactor method for synthesis of drug nanoparticles. Eur. J. Pharm. Biopharm 55:357-360 (2003).
5. R. Hillamo, and E. I. Kauppinen. On the performance of the Berner low pressure impactor. Aerosol Sci. Tech 14:33-47 (1991).
6. J. N. Israelachvili. Intermolecular & surface forces. St Edmundsbury, Suffolk, 1991.
7. J. A. Kurkela, D. P. Brown, J. Raula, and E. I. Kauppinen. Studies on powder deagglomeration into turbulent jet flow. In C. Kanaoka, H. Makino, and H. Kamiya (eds.), Advanced Gas Cleaning Technology, Jugei Shobo, Tokyo, 2005pp. 249-255.
8. D. Lechuga-Ballesteros, and M.-C. Kuo. Dry powder compositions having improved dispersivity. WO 01/32144 (2001).
9. Q. Li, V. Rudolph, and W. Peukert. London-van der Waals adhesiveness of rough particles. Powder Technol 161:248-255 (2006).
10. P. Lucas, K. Anderson, U. J. Potter, and J. N. Staniforth. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm. Res 16:1643-1647 (1999).
11. F. Podczeck. The influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations. Aerosol Sci. Technol 21:301-321 (1999).
12. J. Raula, H. Eerikäinen, and E. I. Kauppinen. Influence of the solvent composition on the morphology of polymer drug composite nanoparticles. Int. J. Pharm 284:13-21 (2004).
13. J. N. Staniforth, and D. A. V. Morton. Magnesium stearate, a phospholipid, or an amino acid in preparation of pharmaceutical particles for inhalation. WO 02/43700 (2002).
14. S. Watano, H. Nakamura, K. Hamada, Y. Wakamatsu, Y. Tanabe, R. N. Dave, and R. Pfeffer. Fine particle coating by a novel rotating fluidized bed coater. Powder Technol 141:172-176 (2004).
15. B. Yue, J. Yang, Y. Wang, C.-Y. Huang, R. Dave, and R. Pfeffer. Particle encapsulation with polymers via in situ polymerization in supercritical CO2. Powder Technol 146:32-45 (2004).
16. X. M. Zeng, G. P. Martin, S.-K. Tee, and C. Marriott. The role of fine particle lactose on the dispersion and deagglomeration of salbutamol sulfate in an air stream in vitro. Int. J. Pharm 176:99-110 (1998).
17. X. M. Zeng, G. P. Martin, and C. Marriott. Particular interactions in dry powder formulations for inhalation. Taylor & Francis, London, 2001.
18. Y. Zhu, and K. W. Lee. Experimental study on small cyclones operating at high flow rates. J. Aerosol Sci 30:1303-1315 (1999).